Biotech ETFs Still Promising Despite Hydroxychloroquine Trial
June 17, 2020 at 15:46 PM EDT
In the continuing quest to find a vaccine for the coronavirus, the World Health Organization announced Wednesday it is dropping hydroxychloroquine, the malaria drug backed by President Trump, who claims it has helped him, from its global study that examines potential treatments for Covid-19. The...